SUZHOU FUSHILAI PHARMACEUTICAL CO., LTD.

News Suzhou Fushilai Pharmaceutical Co., Ltd.

Equities

301258

CNE1000058W2

End-of-day quote Shenzhen S.E. Other stock markets 23:00:00 02/06/2024 BST			5-day change	1st Jan Change
29.11 ^CNY	-2.64%		-5.15%	-9.82%

04-22	Suzhou Fushilai Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-01	Tranche Update on Suzhou Fushilai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on February 6, 2024.	CI

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Suzhou Fushilai Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-22	CI
Tranche Update on Suzhou Fushilai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on February 6, 2024.	04-01	CI
Certain A Shares of Suzhou Fushilai Pharmaceutical Co., Ltd. are subject to a Lock-Up Agreement Ending on 29-MAR-2024.	03-28	CI
Suzhou Fushilai Pharmaceutical Co., Ltd. announces an Equity Buyback for CNY 40 million worth of its shares.	02-06	CI
Suzhou Fushilai Pharmaceutical Co., Ltd. authorizes a Buyback Plan.	02-04	CI
Fushilai Pharmaceutical Co., Ltd. announced that it expects to receive CNY 200 million in funding from Suzhou Fushilai Pharmaceutical Co., Ltd.	12-17	CI
Suzhou Fushilai Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	19/10/23	CI
Suzhou Fushilai Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	21/08/23	CI
Suzhou Fushilai Pharmaceutical Co., Ltd. Announces Cash Dividend on A Shares for 2022, Payable on 08 June 2023	01/06/23	CI
Suzhou Fushilai Pharmaceutical Co., Ltd. Approves the Cash Dividend for the Year 2022	10/05/23	CI
Suzhou Fushilai Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for the Year 2022	18/04/23	CI
Suzhou Fushilai Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	17/04/23	CI
Suzhou Fushilai Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	17/04/23	CI
Certain A Shares of Suzhou Fushilai Pharmaceutical Co., Ltd. are subject to a Lock-Up Agreement Ending on 29-MAR-2023.	28/03/23	CI
Fushilai Pharmaceutical to Apply for 375 Million Yuan Credit Lines This Year	16/03/23	MT
Suzhou Fushilai Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	25/10/22	CI
Suzhou Fushilai Pharmaceutical Co., Ltd. Approves Management Appointments	13/09/22	CI
Suzhou Fushilai Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22/08/22	CI
Suzhou Fushilai Pharmaceutical Co., Ltd. Final Announces Cash Dividend on A Shares for 2021, Payable on June 8, 2022	01/06/22	CI
Suzhou Fushilai Pharmaceutical Co., Ltd. Approves Cash Dividend for 2021	19/05/22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Suzhou Fushilai Pharmaceutical Co., Ltd.

Equities

301258

CNE1000058W2

Summary

Filters